In the News

The University’s institute, dedicated to the environment, continues to work through the pandemic.

UVAToday

People who have recovered from COVID-19 have antibodies that may confer immunity. Sharing them may be helpful to those who are still battling the disease.

UVAToday

The FDA issued emergency-use authorization allowing the use of remdesivir, an antiviral drug tested at UVA Health.

UVAToday

The new fund will serve as a catalyst for vital research focused on COVID-19 testing, therapies, vaccines and even strategies to safely reopen society.

UVAToday

Remdesivir, an antiviral drug tested against COVID-19 at UVA Health and other sites, appeared to improve survival rates and speed recovery times.

UVAToday

Two of the School of Medicine’s leading researchers are teaming to take on something that neither may have attempted on their own: the riddle of spinal cord injuries.

UVAToday

Curry School researchers believe a set of practices designed for classrooms can help families who are social distancing at home.

UVAToday

In the wake of the COVID-19 pandemic, UVA’s Center for Survey Research wants to help people and local agencies in Central Virginia get a better idea of what the future holds.

UVAToday